产品说明
一般描述
(R,R)-(-)-2,3-Bis(tert-butylmethylphosphino)quinoxaline is an air-stable C2-symmetric P-stereogenic phosphine ligand.
应用
Air-Stable and Highly Efficient Chiral Ligands
在合成转化反应中显示高水平手性控制的高效配体，转化反应范围从金属催化芳基硼酸 1,4-加成到烷基化的开环到不对称氢化。
包装
100 mg in clear glass bottle
500 mg in amber glass bottle
特点和优势
Advantages of the QuinoxP* Ligands:
引用
Yahav-Levi A, et al. "Aryl-bromide reductive elimination from an isolated Pt (IV) complex." Chemical Communications 46(19) (2010): 3324-3326.
Fang P and Hou XL. "Asymmetric Copper-Catalyzed Propargylic Substitution Reaction of Propargylic Acetates with Enamines." Organic letters 11.20 (2009): 4612-4615.
Imamoto T, et al. "Highly enantioselective hydrosilylation of simple ketones catalyzed by rhodium complexes of P-chiral diphosphine ligands bearing tert-butylmethylphosphino groups." Tetrahedron: Asymmetry 17(4) (2006): 560-565.
法律信息
QuinoxP is a registered trademark of Nippon Chemical Industry Co., Ltd.
基本信息
| 经验(实验)分子式 | C18H28N2P2 |
| 分子量 | 334.38 |
| MDL编号 | MFCD10565649 |
| PubChem化学物质编号 | 24884852 |
| NACRES | NA.22 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥95% |
| mp | 100-104 ℃ |
| SMILES string | CP(c1nc2ccccc2nc1P(C)C(C)(C)C)C(C)(C)C |
| InChI | 1S/C18H28N2P2/c1-17(2,3)21(7)15-16(22(8)18(4,5)6)20-14-12-10-9-11-13(14)19-15/h9-12H,1-8H3/t21-,22-/m0/s1 |
| InChI key | DRZBLHZZDMCPGX-VXKWHMMOSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H301 - H315 - H319 - H335 - H413 |
| 预防措施声明 | P273 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 3 Oral - Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
| 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
m.cnreagent.com
